PeriGuard Ointment, Petrolatum 49.9%, packaged in a) 5g (NDC 61924-205-05), b) 3.5oz (NDC 61924-205-04), and c) 7oz (NDC 61924-205-07) tubes, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047.

Recall Insight

This FDA Drug action (record #D-0173-2026) was formally reported on November 26, 2025, with the manufacturer initiating the action on August 27, 2025. It is classified under Moderate severity (Class II), with a current status of Ongoing. DermaRite Industries, LLC is listed as the recalling firm, operating out of North Bergen, NJ. Federal records indicate 381,619 units units are affected, a scale large enough to require multi-state distribution tracking.

The documented reason for this recall is: CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated. Distribution data in the federal record shows the product reached: Nationwide in the USA. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 5 were also issued by FDA Drug. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 1 year old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.